Marvell’s falling share price reduced the implied value of its proposed stock payment for Lumentum to $719.10 per share, about 36.5% below the approximately $1,132 initially announced. That was the calculation in 24/7 Wall St.’s November 5, 2026 analysis, republished by Yahoo Finance, using a cited Marvell closing price of $159.80. The agreement fixes the payment at 4.500 Marvell shares for each Lumentum share, so its dollar value moves with Marvell’s stock.

The acquisition remained pending shareholder and regulatory approvals in that reporting. For Lumentum shareholders, the immediate exposure was straightforward: the proposed payment consisted of shares whose market value could rise or fall before closing.

How the fixed exchange ratio changes the offer’s value

Kevin McCormick examines the fixed exchange ratio, changing offer value and investor risks in his English-language financial commentary.

Marvell Technology, Inc. and Lumentum Holdings Inc. announced their definitive, all-stock agreement on November 2, 2026. The exchange ratio, meaning the number of buyer shares offered for each target-company share, was set at 4.500 to one.

The companies valued that package using unaffected share prices as of October 28, 2026. Their approximately $1,132-per-share figure represented a 23.9% premium to Lumentum’s closing price on that reference date. The announced consideration was payable in Marvell shares rather than a guaranteed dollar amount.

Here is how the two valuation references compare:

Valuation referenceBasisImplied value per Lumentum share
Initial company announcement, November 2, 2026Unaffected share prices as of October 28, 2026Approximately $1,132
Calculation published by 24/7 Wall St., November 5, 20264.500 × its cited $159.80 Marvell closing price$719.10

The difference was $412.90 per Lumentum share. Dividing that difference by the initial approximately $1,132 gives a decline of about 36.5% in the implied per-share payment.

The ratio also gives you a useful way to understand the exposure: every $1 move in Marvell stock changes the implied payment for one Lumentum share by $4.50, assuming the terms remain unchanged. A $1 increase adds $4.50; a $1 decrease removes $4.50. That is arithmetic from the agreement, not a stock-price forecast.

According to 24/7 Wall St., the fixed ratio has no price collar, a mechanism that could adjust the terms when the buyer’s stock moves beyond specified thresholds. Lumentum shareholders therefore face Marvell’s share-price movements through the proposed payment itself.

Why the $115 billion headline uses a different measure

The companies initially announced an implied enterprise value of approximately $115 billion. Enterprise value measures the business as a whole, incorporating equity value and debt-related adjustments. The $1,132 figure instead described the implied consideration for one Lumentum share.

In its November 5 analysis, 24/7 Wall St. separately estimated the transaction’s enterprise value at roughly $75 billion to $77 billion. Relative to $115 billion, that range represents a decline of approximately 33% to 35%.

The two calculations answer different questions. The 36.5% figure tracks the changing value of the stock package offered for each Lumentum share. The 33%–35% range describes the publication’s estimate of the broader transaction value. Both depend on valuation inputs; the contractual exchange ratio remained 4.500.

The technology argument behind the proposed combination

Marvell and Lumentum presented the deal as a way to combine semiconductor and optical technologies for AI infrastructure. Marvell CEO Matt Murphy described the intended outcome in a November 2 CNBC interview:

“We're putting the two together to create the category leader in AI connectivity.”— Matt Murphy, Marvell CEO, speaking on CNBC

The industrial argument centers on bringing Marvell’s semiconductor capabilities together with Lumentum’s optical technology for AI data-center connections. In that interview, Murphy defended Lumentum’s indium phosphide and laser technology as highly differentiated. Lumentum CEO Michael Hurlston said the companies needed to move quickly to gain an early position as the semiconductor and optical industries converge.

That explains management’s rationale for pursuing the combination. The financial debate concerns how much shareholders would pay for that strategy through additional shares, integration demands and the time required to complete the transaction.

Dilution and optical-market forecasts divided analysts

Lumentum’s stock also fell. GuruFocus reported that it closed at $625.96 on November 4, 2026, down $54.20, or nearly 8%, for the session.

Analysts raised concerns beyond the exchange-ratio mechanics. In a November 3 report published by Invezz and syndicated on TradingView, Bank of America analyst Vivek Arya questioned whether roughly $1 billion in projected annual cost savings would offset an estimated 50% increase in Marvell’s share count. Bank of America cut its rating from Buy to Neutral and its price target from $400 to $225.

Issuing more shares spreads earnings across a larger ownership base. Whether earnings per share fall depends on how much profit the acquired business and any savings contribute. TD Cowen analyst Sean O’Loughlin estimated that the transaction could reduce earnings per share by a mid-single-digit percentage in calendar 2028. TD Cowen lowered its rating from Buy to Hold and its target from $350 to $175.

The growth assumptions were contested, too. Invezz reported approximately $100 billion in bottom-up consensus estimates for the 2027 optical-transceiver market, compared with TD Cowen’s $47 billion estimate. Optical transceivers convert electrical and optical signals for data connections. Such a wide forecast gap changes how attractive an optical-connectivity acquisition looks before any integration begins.

Analyst opinion was not uniformly negative. The same report said Raymond James raised Lumentum from Outperform to Strong Buy, even as Stifel and B. Riley lowered their ratings.

Individual investors also disagreed. In one Reddit discussion, user besthuman argued that the deal made strategic sense, while other commenters questioned dilution and the long timetable. Those were individual reactions rather than a shareholder vote.

The announced path to closing

The companies projected that existing Marvell shareholders would own approximately 67% of the combined company and Lumentum shareholders approximately 33%, on a fully diluted basis after closing. Matt Murphy was designated to continue as chairman and CEO.

Their November 2 announcement targeted completion in the first half of calendar 2028, subject to shareholder votes, regulatory approvals and other customary closing conditions.